The DOI matches its Crossref record.
Synaptic Plasticity, Dementia and Alzheimer Disease
Abstract
Neuroplasticity is not only shaped by learning and memory but is also a mediator of responses to neuron attrition and injury (compensatory plasticity). As an ongoing process it reacts to neuronal cell activity and injury, death, and genesis, which encompasses the modulation of structural and functional processes of axons, dendrites, and synapses. The range of structural elements that comprise plasticity includes long-term potentiation (a cellular correlate of learning and memory), synaptic efficacy and remodelling, synaptogenesis, axonal sprouting and dendritic remodelling, and neurogenesis and recruitment. Degenerative diseases of the human brain continue to pose one of biomedicine's most intractable problems. Research on human neurodegeneration is now moving from descriptive to mechanistic analyses. At the same time, it is increasing apparently that morphological lesions traditionally used by neuropathologists to confirm post-mortem clinical diagnosis might furnish us with an experimentally tractable handle to understand causative pathways. Consider the aging-dependent neurodegenerative disorder Alzheimer's disease (AD) which is characterised at the neuropathological level by deposits of insoluble amyloid β-peptide (Aβ) in extracellular plaques and aggregated tau protein, which is found largely in the intracellular neurofibrillary tangles. We now appreciate that mild cognitive impairment in early AD may be due to synaptic dysfunction caused by accumulation of non-fibrillar, oligomeric Aβ, occurring well in advance of evident widespread synaptic loss and neurodegeneration. Soluble Aβ oligomers can adversely affect synaptic structure and plasticity at extremely low concentrations, although the molecular substrates by which synaptic memory mechanisms are disrupted remain to be fully elucidated. The dendritic spine constitutes a primary locus of excitatory synaptic transmission in the mammalian central nervous system. These structures protruding from dendritic shafts undergo dynamic changes in number, size and shape in response to variations in hormonal status, developmental stage, and changes in afferent input. It is perhaps not unexpected that loss of spine density may be linked to cognitive and memory impairment in AD, although the underlying mechanism(s) remain uncertain. This article aims to present a critical overview of current knowledge on the bases of synaptic dysfunction in neurodegenerative diseases, with a focus on AD, and will cover amyloid- and nonamyloid- driven mechanisms. We will consider also emerging data dealing with potential therapeutic approaches for ameliorating the cognitive and memory deficits associated with these disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Even more targeted strategies are being developed to enhance neurotransmitter activity.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [210]
In the citing paper
“Examples of medications that may improve synaptic function include those that allosterically increase the M1 muscarinic acetylcholine receptor [209,210].”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [210]
Citations
Cited by
Sorted by citations
Items 101–190 of 190
Xu, C., Zhang, M., Zu, L., Zhang, P., Sun, L., Liu, X., & Fang, M. (2021) · Aging · doi:10.18632/aging.203118 · Cited by 14
“Neurons engage in the processes of capturing, encoding, and saving information, to learn and form memories [1].”
BackgroundA systematic review on drugs for synaptic plasticity in the treatment of dementia
Piscopo, P., Crestini, A., Carbone, E., Rivabene, R., Ancidoni, A., Giudice, M. L., Corbo, M., Vanacore, N., & Lacorte, E. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101726 · Cited by 16
Mohamed-Mohamed, H., García‐Morales, V., Sanchez-Lara, E., González‐Acedo, A., Pardo-Moreno, T., Tovar-Gálvez, M. I., Melguizo‐Rodríguez, L., & Ramos‐Rodríguez, J. J. (2023) · Neurology International · doi:10.3390/neurolint15040079 · Cited by 15
Yang, S., Shi, H., Zeng, P. H., Xia, J., Wang, P., & Li, L. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153624 · Cited by 13
Mudar, R. A., Nguyen, L. T., Eroh, J., Chiang, H., Rackley, A., & Chapman, S. B. (2018) · Brain Research · doi:10.1016/j.brainres.2018.10.017 · Cited by 12
The potential of Terminalia chebula in alleviating mild cognitive impairment: a review
Gao, H., Lu, H., Fang, N., Su, J., Li, R., Wang, W., & Zhang, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1484040 · Cited by 14
“Increasing evidence indicates that phytochemicals have multiple biochemical functions (Skaper et al., 2017).”
BackgroundKouba, B. R., & Rodrigues, A. L. S. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173899 · Cited by 14
Potential mechanisms of non-coding RNA regulation in Alzheimer’s disease
Sun, Y., Pang, X., Huang, X., Liu, D., Huang, J., Zheng, P., Wei, Y., & Pang, C.-Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00696 · Cited by 12
“Additionally, the review omits potential causes of AD, including oxidative stress and the detrimental effects of metal ions such as iron and copper, both of which are associated with disease progression.”
Zhao, Y., Long, Z., Liu, Y., Luo, M., Qiu, Y. L., Idris, N. F. B., Song, A., Wang, K., & He, G. (2021) · Current Alzheimer Research · doi:10.2174/1567205017666201215124746 · Cited by 11
Sharma, H. S., Muresanu, D. F., Nozari, A., Lafuente, J. V., Buzoianu, A. D., Sahib, S., Tian, Z. R., Bryukhovetskiy, I., Manzhulo, I., Menon, P. K., et al. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.04.008 · Cited by 11
Wang, Q., Liu, T., Chang, H., Li, Z., Chen, L., Mi, X., Xing, H.-Y., Wang, X., Hong, J., Liu, K., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13040657 · Cited by 10
Spector, A. E., Wahab, N. D. A., Stott, J. C. H., Fisher, E., Hui, E. K., Perkins, L., Leung, W. G., Evans, R., Wong, G. H. Y., & Felstead, C. (2024) · The Gerontologist · doi:10.1093/geront/gnae063 · Cited by 15
“It is built upon several theories including learning theory and brain plasticity (Skaper et al., 2017), which suggest that appropriate and targeted mental stimulation, for example, through building new semantic connections, can lead to the development of new neuronal pathways.”
BackgroundZhang, N., Nao, J., & Dong, X. (2024) · Current Neuropharmacology · doi:10.2174/1570159x23666241211095018 · Cited by 13
“It has been shown that Aβ and tau oligomers accumulate in the extracellular and synaptic cytoplasm, respectively, in areas demonstrating substantial synaptic loss, and removal of these proteins improves synaptic function [152].”
Promising Natural Remedies for Alzheimer’s Disease Therapy
Thawabteh, A. M., Ghanem, A. W., AbuMadi, S., Thaher, D., Jaghama, W., Karaman, D., & Karaman, R. (2025) · Molecules · doi:10.3390/molecules30040922 · Cited by 13
Xie, Y., Zhao, J., Li, X., et al. (2023) · Toxics · doi:10.3390/toxics11120999 · Cited by 10
Fu, Y., Hu, T., Zhang, Q., Meng, S., Lu, Y., Xiang, A., Yin, Y., Li, Y., Song, J., & Wen, D. (2021) · Disease Markers · doi:10.1155/2021/2629150 · Cited by 10
“Previous studies have shown that the early newborn synapses are established rapidly after injury [35].”
ResultLiang, R., Wang, L., Yang, Q., Xu, Q., Sun, S., Zhou, H., Zhao, M., Gao, J., Zheng, C., Yang, J., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1275771 · Cited by 10
“On the one hand, some studies have shown that an increase in oxidative stress can lead to a decrease in synaptic protein expression, resulting in reduced intercellular signal transmission (Cai et al., 2016; Skaper et al., 2017; Thangwong et al., 2022).”
BackgroundSocial isolation impairs cognition via Aβ-mediated synaptic dysfunction
Huang, F., Liu, X., Guo, Q., Mahaman, Y. A. R., Zhang, B., Wang, J., Luo, H., Liu, R., & Wang, X. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03078-5 · Cited by 11
“In the TST, the immobility time was longer and the latency to immobility was shorter in the APP/PS1-SI group compared to the APP/PS1-HC group, suggesting that SI exacerbated depressive-like behaviour in APP/PS1 mice (Fig.”
ResultRong, X., Yao, X., Fang, H., Saji, J., Qian, Y., Gu, J.-X., Yang, M., Peng, W., Liu, C.-R., Chen, B., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01869-6 · Cited by 12
Ahnaou, A., Heleven, K., Biermans, R., Manyakov, N. V., & Drinkenburg, W. H. I. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168672 · Cited by 10
Yang, J., Wang, J., Hu, Y., Shen, D.-Y., Xiao, G.-L., Qin, X., & Lan, R. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.104406 · Cited by 9
Huang, P., Lin, L., Zhang, J., Cheng, Y., & Pan, X. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2293225 · Cited by 10
“Recent studies found that the pathophysiological changes in the early stage of AD may result from the accumulation of oligomeric amyloid beta (Abeta) protein, which impairs synaptic plasticity [4], an important neurophysiological process involved in the reorganization of brain networks after injury.”
BackgroundModelling neurodegenerative diseases in vitro: Recent advances in 3D iPSC technologies
Siney, E. J., Kurbatskaya, K., Chatterjee, S., Prasannan, P., Mudher, A. K., & Willaime‐Morawek, S. (2018) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2018.1.1 · Cited by 9
“(thought to be disrupted in early AD and lead to memory loss [105]), live imaging of calcium dynamics (to model early calcium changes in AD [106]) or axonal transport (which is impaired as a result of tau dysfunction in AD models [107,108]) and an array of molecular and biochemical analyses to identify the transcripti…”
BackgroundChuanxiong-Danggui herb pair alleviated cognitive deficits of APP/PS1 mice by promoting mitophagy
Pu, K., Yang, S., Sheng, R., Chen, J., Dai, Y., Wood, I. C., Zhong, Z., & Xu, S. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119988 · Cited by 10
Chiang, M., Nicol, C. J. B., Yang, Y., Chiang, T., & Yen, C. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149506 · Cited by 7
Zou, Y., Guo, Q., Chang, Y., Zhong, Y., Cheng, L. Z., & Wei, W. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110518 · Cited by 7
Hippocampal proteomic changes in high-fat diet-induced obese mice associated with memory decline
Lu, P., Gao, C.-X., Luo, F.-J., Huang, Y.-T., Gao, M., & Long, Y. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109554 · Cited by 7
Zong, Q., Pan, Y., Liu, Y., Wu, Z., Huang, Z., Zhang, Y., & Ma, K. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109727 · Cited by 8
Exercise to Counteract Alzheimer’s Disease: What Do Fluid Biomarkers Say?
Bonanni, R., Cariati, I., Cifelli, P., Frank, C., Annino, G., Tancredi, V., & D’Arcangelo, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136951 · Cited by 8
Sarahian, N., Khodagholi, F., Valian, N., & Ahmadiani, A. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115235 · Cited by 6
Qi, J., Wang, Z.-J., Yang, G., Gao, Q.-C., Li, W.-R., Cai, H.-Y., Zhao, H., Wang, J.-J., Zhao, X., Wang, J.-X., et al. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335168 · Cited by 6
“It is believed that the plasticity of synaptic structure is important for dementia (Skaper et al., 2017).”
BackgroundMegari, K., & Genova, K. D. (2025) · IGI Global eBooks · doi:10.4018/979-8-3693-9689-6.ch006 · Cited by 5
Decoding the neuroprotective potential of hesperidin: Insights into Alzheimer’s disease
Chauhan, P., Vadia, N., Ballal, S., Joshi, K. K., Maharana, L., Chauhan, A. S., Abomughaid, M. M., Lakhanpal, S., Avinash, D., Thakur, K., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.09.028 · Cited by 7
Gao, C., Qin, G., Zheng, M., Tian, M., He, Y., & Wang, P. (2023) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-023-3606-3 · Cited by 7
“(40) In this study, BXD treatment significantly reversed the reduction in SYP and PSD95 expression in APP/PS1 mice, thus indicating that BXD intervention can reshape abnormal synaptic plasticity in AD.”
Aksic, M., Jakovčevski, I., Hamad, M. I. K., Jakovljevic, V. L., Stankovic, S. D., & Vulović, M. (2024) · Biomedicines · doi:10.3390/biomedicines12081726 · Cited by 5
“Although various currently available strategies directed toward the reduction or clearance of amyloid plaque deposition were insufficient to cure fully developed AD, it is conceivable that some future development of early diagnostic methods will increase therapeutic success [17].”
BackgroundLi, Y., Zhang, Q., Yan, W., Wang, X., Yu, J., Yin, C., Zhou, Q., Hou, Z., & Wang, Q. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.996223 · Cited by 5
“Moreover, the regulation of synaptic plasticity has a certain therapeutic effect on neurodegenerative changes (Skaper et al., 2017) and is involved in the reconstruction of brain networks following brain injury.”
BackgroundRetractedKarsuntseva, E. K., Voronova, A. D., Andretsova, S. S., Shishkina, V. S., Chadin, A. V., Fursa, G. A., Fedorov, A. V., Reshetov, I. V., Stepanova, O. V., & Chekhonin, V. P. (2024) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-024-06293-8 · Cited by 5
“AD is associated with significant impairment of synaptic plasticity and neu - ronal death [29], which leads to cognitive impairment [30].”
Moghaddam, M. H., Hatari, S., Shahidi, A. M. E. J., Nikpour, F., Omran, H. S., Fathi, M., Vakili, K. G., Abdollahifar, M., Tizro, M., Eskandari, N., et al. (2022) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2022.102071 · Cited by 4
DNA Methylation in Aging and Alzheimer's Disease
Cheng, R., Shu, J., Chen, H., Li, M., Cheng, X., & Liu, L. (2024) · Human Brain · doi:10.37819/hb.3.2027 · Cited by 5
“The exact causes and functional consequences of these methylation changes remain incompletely understood, as do their links to aging, longevity, and disease.”
Okhovat, M., Layman, C. E., Davis, B. A., Pederson, A., O’Niel, A., Holden, S. J., Kessler, K., Acharya, S. N., Wheeler, K. J., Nevonen, K. A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-28244-7 · Cited by 6
“PTK2B is implicated in AD through its involvement in synaptic plasticity, calcium signaling, and neuroinflammatory pathways, all of which are disrupted in AD 18–20 .”
Zhang, B., Yu, X., & Zhang, X. (2026) · Neurological Sciences · doi:10.1007/s10072-026-08893-w · Cited by 6
Zhang, X., Li, D., Zeng, W., Huang, Y., Zhan, Z., Zhang, Y., Hu, Q., Huang, L., & Yu, M. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00394 · Cited by 5
“Under pathological conditions, such as in some neurodegenerative diseases, synaptic plasticity may be disrupted, thereby impacting the neural circuitry (Bae and Kim, 2017; Skaper et al., 2017; Batool et al., 2019; Chu, 2020; Dorszewska et al., 2020; Niraula et al., 2023, 2024).”
Coordinated Actions of Neurogenesis and Gliogenesis in Nerve Injury Repair and Neuroregeneration
Chen, M., Chi, C.-Y., Zheng, C.-W., Wang, C.-H., & Chiu, I. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4040053 · Cited by 4
“…diseases is related to various pathological mechanisms, including neuroinflammation [2,3], oxidative stress [4,5], immune dysregulation [6], neurotransmitter disruption [7], synaptic plasticity damage [2,8], and neuroendocrine disorders [5], leading to the gradual loss of neurons and glial cells.”
Polini, B., Ricardi, C., Lupo, F. D., Runfola, M., Bacci, A., Rapposelli, S., Bizzarri, R., Scalese, M., Saponaro, F., & Chiellini, G. (2025) · Cells · doi:10.3390/cells14080580 · Cited by 5
“Subsequent release of neurotoxic substances can disrupt the integrity of the blood-brain barrier (BBB), which is already compromised due to systemic inflammation [57].”
Redina, O. E., Babenko, V. N., Смагин, Д. А., Kovalenko, I. L., Galyamina, A. G., Efimov, V. M., & Kudryavtseva, N. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033040 · Cited by 4
Therapeutic Potential of Ascorbic Acid in the Management of Alzheimer's Disease: An Update
Semwal, B. C., Singh, B. K., Murti, Y., & Singh, S. K. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666230804102617 · Cited by 4
Deng, Y. L., Chen, C., Li, H., Wang, T., Zhang, X., Wang, X., & Pan, G. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266347052250407110353 · Cited by 3
“Improving synaptic morphology and promoting synaptic transmission plasticity are promising strategies for mitigating cognitive decline in AD patients [13, 14].”
Bone-brain crosstalk: emerging roles of osteocalcin in central nervous system disorders
Chen, H., Zhang, Z., Yi, W., Wang, N., Dong, X., Xing, Y., Liu, Q., Wu, Y., & Ma, X. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.028 · Cited by 6
Shi, Y., Bao, Q., Chen, W., Wang, L., Peng, D., Liu, J., Liu, Q., Zhang, Y., Ji, Z., & Shen, A. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215666 · Cited by 3
“At present, detecting the insoluble A (cid:2) in extracellular plaque and tau proteins in intracellular tangles after death is the exact diagnosis of AD [13, 14].”
Lorenzini, L., Ingala, S., Wottschel, V., Wink, A. M., Mutsaerts, H. J. M. M., Haller, S., Blennow, K., O'Brien, J. T., Frisoni, B. G., Chételat, G., et al. (2022) · Aging Brain · doi:10.1016/j.nbas.2022.100054 · Cited by 3
“Progressive synaptic loss as the disease progresses shows a close correspondence with cognitive decline [49].”
BackgroundLiu, J., Xie, J., Dutta, D., & Xiong, H. (2023) · PubMed Central · Cited by 3
Receptor tyrosine kinases in Alzheimer's disease: Mechanistic insights and therapeutic implications
Zhao, P., Cao, Z., & Rozpędek‐Kamińska, W. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106117 · Cited by 2
Synapse-associated neuropathological markers in Alzheimer's disease
Barrantes, F. J. (2026) · Brain · doi:10.1093/brain/awag117 · Cited by 2
Neurodevelopment During Adolescence
Velthuis, H., & McAlonan, G. M. (2022) · In clinical practice · doi:10.1007/978-3-030-98808-1_2 · Cited by 4
Abozaid, A., Scaramuzzo, M., Patel, H., & Gerlai, R. T. (2025) · Zebrafish · doi:10.1089/zeb.2024.0176 · Cited by 2
“3 Despite decades of research on the psychological, neurobiological, biochemical, and molecular genetic mechanisms underlying learning and memory, we still do not fully understand these phenomena.”
Wang, Q., Liu, T., Chang, H., Li, Z., Chen, L., Xing, H.-Y., Wang, X., Hong, J., Liu, K., Li, Y., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2096018/v1 · Cited by 2
Uncovering the dark transcriptome in polarized neuronal compartments with mcDETECTPreprint
Yuan, C., Patel, K., Shi, H., Wang, H. V., Wang, F., Li, R.-H., Li, Y., Corces, V. G., Shi, H., Das, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.27.645744 · Cited by 4
Tarasova, I. V., & Trubnikova, O. A. (2024) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2401215 · Cited by 1
Liu, Z., Hu, B., Tang, J., Liu, X., Cheng, B., Jia, C., & Zhang, L. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241289381 · Cited by 2
“5 ’ Timeline [#7] in Figure 7.”
The Role of Acupuncture Improving Cognitive Deficits through Regulating Neuroplasticity
Ji, S., Duan, J., Tan, M., Zhang, Y., & Chan, P. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1010850 · Cited by 1
Synaptic Vesicle Cycle: From Mechanistic Insights to Epigenetic Perspectives
Gupta, S., Kishore, A., Rishi, V., & Aggarwal, A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00684 · Cited by 1
Marschner, R. A., Ribeiro, R. T., Gayger-Dias, V., Silva, V.-F. D., Wajner, S. M., & Gonçalves, C. (2026) · Scientific Reports · doi:10.1038/s41598-026-43232-1 · Cited by 1
Saragih, I. D., Hwang, P., Yadav, D., Qiu, L., Fick, D. M., Sundar, S. S., & Abdullah, S. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07180-9 · Cited by 2
Seasonal comparison of the neuromuscular junction morphology of Bufo marinus
Ge, D., Noakes, P. G., & Lavidis, N. A. (2019) · The Journal of Comparative Neurology · doi:10.1002/cne.24661 · Cited by 1
Neurological perspectives on aging
Yemişçi, M., & Karataş, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98804-9.00011-6 · Cited by 1
Liu, J., Yin, X., & Dong, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-75694-6 · Cited by 1
“Synaptic plasticity injury was one of the pathological mechanisms for AD 72,73 .”
BackgroundPathological Synaptic Plasticity in Neurological Disorders
Jin, C., & Karlstedt, K. (2025) · Synaptic Plasticity - Neurobiology, Neuroanatomy, and Clinical Neuroscience · doi:10.5772/intechopen.1007753 · Cited by 1
Li, X., Gong, Z., Zhu, N., & Zhang, S. (2025) · Avian Research · doi:10.1016/j.avrs.2025.100303 · Cited by 1
(-)-Epigallocatechin-3-gallate and Alzheimer's disease
Xicota, L., & de la Torre, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00050-5 · Cited by 1
JALR. New Journal, Old questions, Fresh insights
Paganelli, R. (2017) · Journal of Alzheimers Research and Therapy · doi:10.14302/issn.2998-4211.jalr-17-1884
New Prospects for Stem Cell Therapy in Alzheimer’s Disease
Jiang, K., Zhu, Y., & Zhang, L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100334
Tan, B., Babür, E., Süer, C., et al. (2021) · Genel Tıp Dergisi · doi:10.54005/geneltip.1036595
NEUROFEEDBACK COMO TRATAMENTO DA DOENÇA DE ALZHEIMER: UMA REVISÃO NARRATIVA
Muzzolon, E., Ratis, R. C., & Bonini, J. S. (2022) · Editora Científica Digital eBooks · doi:10.37885/211006487
Miranda, F. D. (2022) · Psych-Talk · doi:10.53841/bpstalk.2022.1.103.50
Behrooz, A. B., Aghanoori, M., Khodagholi, F., Nazari, M., Latifi, H., vosoghian, F., Anjomani, M., Lotfi, J., Ahmadiani, A., Eliassi, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.12.593775
“Decreased neuronal plasticity is another hallmark of neurodegenerative diseases such as AD [73].”
BackgroundParsons, S. (2024) · International Journal of Clinical Case Reports and Reviews · doi:10.31579/2690-4861/428
Pu, K., Yang, S., Sheng, R., Chen, J., Zhong, Z., & Xu, S. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5076382
Jones, T., Shalom, M., Chalamgari, A., Gold, J. L., Zomalan, B., Patel, S., Munjal, V., Khan, M. F., Mao, Y., Gendreau, J. L., et al. (2025) · Cureus · doi:10.7759/cureus.85156 · Cited by 1
Wright, W., & Komiyama, T. (2025) · doi:10.64628/aai.ugdm6asdk
Role of diabetes and altered metabolic homeostasis in age-related dementia
Biswas, T., Ahmed, M. A., Bhowmick, S., & Mondal, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00028-1
Baghcheghi, Y., Razazpour, F., Mohammadi, M., Mashayekhi‐Sardoo, H., & Hedayati‐Moghadam, M. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251412327
Healing through movement: narrative review on exercise and neurological disorders
Essa, S. M., Kakar, A., Khosa, N. A., Ibrahim, I. A., Jovanovic, M., Mclaughlin, M. L., Ibrahim, M. M., & Riddle, K. (2025) · Asia-Pacific Journal of Surgical & Experimental Pathology · doi:10.32948/ajsep.2025.10.28
Bacopa monnieri Promotes Neuronal Development by Regulating the Neurotrophin Signaling Pathway
Dash, R., Mitra, S., Dash, N., Barua, L., Mazumder, K., & Moon, I. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073048 · Cited by 1
Development of the Nervous System During Adolescence
Aigbogho, U. G. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-981-95-7000-3_5
Carrasco, M., Guzman, L., Barroso, E., Olloquequi, J., Cano, A., Ureña, J., Verdaguer, E., Prohens, R., Fortuna, A., Auladell, C., et al. (2026) · GeroScience · doi:10.1007/s11357-026-02321-9
Targeted neuronal reprogramming rescues memory and neural synchrony in Alzheimer’s disease
Galán-Ganga, M., Rodríguez-Navarro, I., Zaballa, S., Ramón-Lainez, A., Gómez-Rivada, N., Peters, C., Fernández‐Irigoyen, J., Santamaría, E., Rabadán, M. A., Alberch, J., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00481-w
“Among these, one of the most critical and severely affected features is the loss of neural connectivity and synaptic plasticity [6, 7].”
Anand, A., Sania, A., Singh, S. K., & Bajad, N. G. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06078-2 · Cited by 1
“In the brains of patients with Alzheimer’s disease, the capability of the synapses to transform and modify is impaired, resulting in defects in memory and eventual cognitive decline [35].”
Alreshidi, N. F., Alghamdi, A. A., Almasoudi, K. S., Mirza, I. M., Abduljawad, S. A., Zakaria, S. S., Alharbi, S. S., & Initiative, A. D. N. (2026) · European Geriatric Medicine · doi:10.1007/s41999-026-01562-3
Metadata
- Authors
- Skaper, S. D., Facci, L., Zusso, M., & Giusti, P.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Giusti, Pietro
- Venue
- CNS & Neurological Disorders - Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2017-04-12
- Volume
- 16
- Issue
- 3
- Pages
- 220-233
- ISSN
- 1568-007X (ISSN-L)
- 1871-5273
- OpenAlex
- W2573085547
- Cited by
- 192
- References
- 0
- Citations by year
- 2026: 13 · 2025: 23 · 2024: 27 · 2023: 30 · 2022: 33 · 2021: 25 · 2020: 13 · 2019: 13 · 2018: 12 · 2017: 3
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS & Neurological Disorders - Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- synaptic plasticity, Alzheimer's disease, dementia, neurodegeneration, amyloid-beta oligomers, tau protein, dendritic spines, synaptic dysfunction, long-term potentiation, synaptogenesis, axonal sprouting, neurogenesis, mild cognitive impairment, memory impairment, treatment options
- MeSH terms
- Alzheimer Disease, Dementia, Humans, Neuronal Plasticity, Synapses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review